Topical Ectoine Urea St John's Wort Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for psoriasis and atopic eczema often result in insufficient therapeutic success and significant side effects, with existing medications failing to adequately address the severe itching and skin damage associated with these conditions.
Innovation Solution
A pharmaceutical composition combining ectoine or its derivatives with urea and St. John's wort (Hypericum perforatum L.), in specific ratios, to create a synergistic effect that provides effective skin protection and healing, reducing side effects and improving treatment outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (cortisone, dithranol, coal tar) are used for psoriasis and atopic eczema, then therapeutic effects are achieved, but side effects increase and treatment complexity increases
Solution Approach 1:
The patent combines three active ingredients (ectoine, urea, and St. John's wort extract) into a single topical preparation, creating a synergistic effect that provides therapeutic benefits while reducing the need for multiple separate treatments and their associated side effects
Solution Approach 2:
The invention uses a composite formulation containing ectoine (a protective osmolyte), urea (a keratolytic and moisturizing agent), and St. John's wort extract (an anti-inflammatory), creating a multi-functional material that addresses multiple aspects of skin disease pathology simultaneously
2Reliability
If high concentrations of active ingredients are used to improve therapeutic effect, then treatment efficacy increases, but side effects and skin irritation increase
Solution Approach 1:
The patent optimizes the concentration parameters of each active ingredient within specific ranges (ectoine: 0.1-10%, urea: 5-40%, St. John's wort extract: 0.01-5%) to achieve maximum therapeutic effect while minimizing skin irritation and side effects
Solution Approach 2:
The formulation provides different functional components that act on different aspects of skin pathology locally - ectoine provides cellular protection and anti-inflammatory effects, urea provides keratolytic and moisturizing effects, and St. John's wort provides anti-inflammatory and healing effects, with each component optimized for its specific function
3Adaptability or versatility
If multiple separate treatments are applied to address different symptoms, then comprehensive symptom management is achieved, but treatment complexity and time increase
Solution Approach 1:
The single topical preparation performs multiple functions simultaneously: protecting skin cells from damage, reducing inflammation, moisturizing dry skin, promoting healing, and preventing bacterial colonization, thereby replacing multiple separate treatments with one versatile formulation
Solution Approach 2:
The patent merges the functions of multiple separate medications into one unified preparation, combining cell protection, anti-inflammatory, moisturizing, and healing properties in a single application that simplifies the treatment regimen
Data Source
AI summary
The invention relates to a compound, in particular a pharmaceutical compound, which is suitable preferably for the topical treatment of skin diseases, wherein the compound - each constituent in effective, in particular pharmaceutically effective, quantities - comprises a combination of (a) ectoin and/or at least one ectoin derivative, together with (b) urea and/or at least one urea derivative, and/or with (c) at least one constituent of St. John's wort (Hypericum perforatum L.).